142 related articles for article (PubMed ID: 16384676)
1. Contributions of intestinal P-glycoprotein and CYP3A to oral bioavailability of cyclosporin A in mice treated with or without dexamethasone.
Jin M; Shimada T; Yokogawa K; Nomura M; Kato Y; Tsuji A; Miyamoto K
Int J Pharm; 2006 Feb; 309(1-2):81-6. PubMed ID: 16384676
[TBL] [Abstract][Full Text] [Related]
2. Site-dependent contributions of P-glycoprotein and CYP3A to cyclosporin A absorption, and effect of dexamethasone in small intestine of mice.
Jin M; Shimada T; Yokogawa K; Nomura M; Ishizaki J; Piao Y; Kato Y; Tsuji A; Miyamoto K
Biochem Pharmacol; 2006 Oct; 72(8):1042-50. PubMed ID: 16939683
[TBL] [Abstract][Full Text] [Related]
3. Modulation of mdr1a and CYP3A gene expression in the intestine and liver as possible cause of changes in the cyclosporin A disposition kinetics by dexamethasone.
Yokogawa K; Shimada T; Higashi Y; Itoh Y; Masue T; Ishizaki J; Asahi M; Miyamoto K
Biochem Pharmacol; 2002 Feb; 63(4):777-83. PubMed ID: 11992648
[TBL] [Abstract][Full Text] [Related]
4. Brain cyclosporin A levels are determined by ontogenic regulation of mdr1a expression.
Goralski KB; Acott PD; Fraser AD; Worth D; Sinal CJ
Drug Metab Dispos; 2006 Feb; 34(2):288-95. PubMed ID: 16303871
[TBL] [Abstract][Full Text] [Related]
5. Long-term levothyroxine treatment decreases the oral bioavailability of cyclosporin A by inducing P-glycoprotein in small intestine.
Jin M; Shimada T; Shintani M; Yokogawa K; Nomura M; Miyamoto K
Drug Metab Pharmacokinet; 2005 Oct; 20(5):324-30. PubMed ID: 16272749
[TBL] [Abstract][Full Text] [Related]
6. Using real-time quantitative TaqMan RT-PCR to evaluate the role of dexamethasone in gene regulation of rat P-glycoproteins mdr1a/1b and cytochrome P450 3A1/2.
Mei Q; Richards K; Strong-Basalyga K; Fauty SE; Taylor A; Yamazaki M; Prueksaritanont T; Lin JH; Hochman J
J Pharm Sci; 2004 Oct; 93(10):2488-96. PubMed ID: 15349958
[TBL] [Abstract][Full Text] [Related]
7. Influence of cytarabine and cyclophosphamide on the disposition kinetics of cyclosporin A after bone marrow transplantation.
Shimada T; Aoki Y; Yokogawa K; Nomura M; Ishizaki J; Nishigami J; Miyamoto K
Transpl Int; 2003 Nov; 16(11):788-93. PubMed ID: 12844214
[TBL] [Abstract][Full Text] [Related]
8. Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir.
Bardelmeijer HA; Ouwehand M; Buckle T; Huisman MT; Schellens JH; Beijnen JH; van Tellingen O
Cancer Res; 2002 Nov; 62(21):6158-64. PubMed ID: 12414642
[TBL] [Abstract][Full Text] [Related]
9. An antioxidant Trolox restores decreased oral absorption of cyclosporine A after liver ischemia-reperfusion through distinct mechanisms between CYP3A and P-glycoprotein in the small intestine.
Ikemura K; Inoue K; Mizutani H; Oka H; Iwamoto T; Okuda M
Eur J Pharmacol; 2012 Sep; 690(1-3):192-201. PubMed ID: 22749977
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of decrease of oral bioavailability of cyclosporin A during immunotherapy upon coadministration of amphotericin B.
Ishizaki J; Ito S; Jin M; Shimada T; Ishigaki T; Harasawa Y; Yokogawa K; Takami A; Nakao S; Miyamoto K
Biopharm Drug Dispos; 2008 May; 29(4):195-203. PubMed ID: 18240156
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Targeted Absolute Proteomics of Transporters and Pharmacoproteomics-Based Reconstruction of P-Glycoprotein Function in Mouse Small Intestine.
Akazawa T; Uchida Y; Tachikawa M; Ohtsuki S; Terasaki T
Mol Pharm; 2016 Jul; 13(7):2443-56. PubMed ID: 27276518
[TBL] [Abstract][Full Text] [Related]
12. Brain penetration of ivermectin and selamectin in mdr1a,b P-glycoprotein- and bcrp- deficient knockout mice.
Geyer J; Gavrilova O; Petzinger E
J Vet Pharmacol Ther; 2009 Feb; 32(1):87-96. PubMed ID: 19161460
[TBL] [Abstract][Full Text] [Related]
13. Impact of P-glycoprotein and breast cancer resistance protein on the brain distribution of antiepileptic drugs in knockout mouse models.
Nakanishi H; Yonezawa A; Matsubara K; Yano I
Eur J Pharmacol; 2013 Jun; 710(1-3):20-8. PubMed ID: 23588114
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387.
Durmus S; Xu N; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
Pharmacol Res; 2013 Oct; 76():9-16. PubMed ID: 23827160
[TBL] [Abstract][Full Text] [Related]
15. Individual and combined roles of CYP3A, P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) in the pharmacokinetics of docetaxel.
van Waterschoot RA; Lagas JS; Wagenaar E; Rosing H; Beijnen JH; Schinkel AH
Int J Cancer; 2010 Dec; 127(12):2959-64. PubMed ID: 21351274
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
Yumoto R; Murakami T; Sanemasa M; Nasu R; Nagai J; Takano M
Drug Metab Dispos; 2001 Feb; 29(2):145-51. PubMed ID: 11159804
[TBL] [Abstract][Full Text] [Related]
17. Morphological and functional changes in p-glycoprotein during dexamethasone-induced hepatomegaly.
Micuda S; Fuksa L; Mundlova L; Osterreicher J; Mokry J; Cermanova J; Brcakova E; Staud F; Pokorna P; Martinkova J
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):296-303. PubMed ID: 17324141
[TBL] [Abstract][Full Text] [Related]
18. Disposition of the cholesterol absorption inhibitor ezetimibe in mdr1a/b (-/-) mice.
Oswald S; Koll C; Siegmund W
J Pharm Sci; 2007 Dec; 96(12):3478-84. PubMed ID: 17828742
[TBL] [Abstract][Full Text] [Related]
19. Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug.
Jonker JW; Wagenaar E; van Deemter L; Gottschlich R; Bender HM; Dasenbrock J; Schinkel AH
Br J Pharmacol; 1999 May; 127(1):43-50. PubMed ID: 10369454
[TBL] [Abstract][Full Text] [Related]
20. Capsaicin pretreatment increased the bioavailability of cyclosporin in rats: involvement of P-glycoprotein and CYP 3A inhibition.
Zhai XJ; Shi F; Chen F; Lu YN
Food Chem Toxicol; 2013 Dec; 62():323-8. PubMed ID: 24013073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]